Your browser doesn't support javascript.
loading
Concordance of hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode Statistics among patients treated with oral antidiabetic therapies.
Saine, M Elle; Carbonari, Dena M; Newcomb, Craig W; Gallagher, Arlene M; Blak, Betina T; Roy, Jason A; Wood, Jennifer; Cardillo, Serena; Hennessy, Sean; Strom, Brian L; Lo Re, Vincent.
Afiliación
  • Saine ME; Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Carbonari DM; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Newcomb CW; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
  • Gallagher AM; Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Blak BT; Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Roy JA; Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, UK.
  • Wood J; AstraZeneca UK Limited, Luton, UK.
  • Cardillo S; Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Hennessy S; Rutgers Biomedical & Health Sciences, The State University of New Jersey, Newark, NJ, USA.
  • Strom BL; Department of Global Pharmacovigilance and Epidemiology, Bristol-Myers Squibb, Hopewell, NJ, USA.
  • Lo Re V; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Pharmacoepidemiol Drug Saf ; 28(10): 1328-1335, 2019 10.
Article en En | MEDLINE | ID: mdl-31328342
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Admisión del Paciente / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Admisión del Paciente / Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos